Output Biosciences

Adi Mashiach, MD

Adi is a repeat founder of AI-driven biotech startups, former physician, and computational systems biology researcher. He was the founder of Nyxoah (NASDAQ:NYXH), a leading sleep apnea therapy based on a neurotech and adaptive learning platform. He founded Innovea (acquired), a medical imaging startup focused on diffusion-based computer vision. His innovative research in machine learning and nonlinear dynamics predicted cancer therapy responses from cell images. Adi holds over 85 US patents.

Adi Mashiach

Serial entrepreneur, former OBGYN and computational biology researcher. Previously founder CEO of Nyxoah (NASDAQ: NYXH) and Innovea (acquired), a medical computer vision startup.

Mirella Mashiach

Big pharma executive and biotech investor. Former Managing Director of the $200M corporate venture biotech fund at Teva Pharmaceuticals and VP of BD and Strategy. Previously an attorney at Dentons focused on life sciences and medical devices.